WiseGuyReports

Hyaluronic Acid Global Market Expected to Grow at CAGR 8.7% and Forecast to 2021

The analysts forecast the global hyaluronic acid market to grow at a CAGR of 8.7% during the period 2017-2021.

 

New York, NY -- (SBWIRE) -- 08/16/2018 -- Global Hyaluronic Acid Market

WiseGuyRerports.com Presents "Global Hyaluronic Acid Market 2017-2021" New Document to its Studies Database. The Report Contain 86 Pages With Detailed Analysis.

Description

HA is an anionic and non-sulfated glycosaminoglycan, which is present in human body especially in the joints in the form of fluids; it acts as a lubricant, thereby providing a cushioning effect. HA is primarily used in medical and cosmetic applications such as dermal fillers, osteoarthritis, ophthalmic surgery, and VUR. In addition, it helps in the healing of wounds. The rising demand for cosmetics and non-surgical procedures is expected to drive the growth of the HA market.

The analysts forecast the global hyaluronic acid market to grow at a CAGR of 8.7% during the period 2017-2021.

Covered in this report
The report covers the present scenario and the growth prospects of the global hyaluronic acid market for 2017-2021. The report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

 

Get sample Report @ https://www.wiseguyreports.com/sample-request/2373810-global-hyaluronic-acid-market-2017-2021

 

The market is divided into the following segments based on geography:
- APAC
- Europe
- North America
- ROW

The Global Hyaluronic Acid Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
- ALLERGAN
- Anika Therapeutics
- Sanofi
- SEIKAGAKU
- Zimmer Biomet

Other prominent vendors
- Contipro
- Ferring
- Fidia Farmaceutici
- Galderma
- Hyalogic
- HYALTECH
- Lifecore Biomedical
- Maruha Nichiro
- Meiji Holdings
- Merz Pharma
- Rayner
- Shiseido
- TRB CHEMEDICA INTERNATIONAL
- Valeant

Market driver
- Increased ailments among the growing aging population
- For a full, detailed list, view our report

Market challenge
- Intense competition leading to reduced ASP
- For a full, detailed list, view our report

Market trend
- Production of HA with cost-effective raw materials
- For a full, detailed list, view our report

Key questions answered in this report
- What will the market size be in 2021 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?

 

Complete Report Details @ https://www.wiseguyreports.com/reports/2373810-global-hyaluronic-acid-market-2017-2021

 

Table of Contents -Major Key Points

PART 01: Executive summary 

PART 02: Scope of the report 

PART 03: Research Methodology 

PART 04: Introduction
- Market outline

PART 05: Market landscape
- Market overview
- Market size and forecast
- Five forces analysis

PART 06: Market segmentation by product
- Global HA market by product type
- Global five-injection cycle HA market
- Global three-injection cycle HA market
- Global single-injection cycle HA market

PART 07: Market segmentation by application
- Global HA market by application
- Global HA market in the dermal fillers segment
- Global HA market in the osteoarthritis segment
- Global HA market in the ophthalmic surgery segment
- Global HA market in the VUR segment

PART 08: Geographical segmentation
- Global HA market by geography
- HA market in North America
- HA market in Europe
- HA market in APAC
- HA market in ROW

PART 09: Decision framework 

PART 10: Drivers and challenges
- Market drivers
- Market challenges

PART 11: Market trends
- Production of HA with cost-effective raw materials
- Rising substitutes for HA

PART 12: Vendor landscape
- Competitive scenario
- Key market vendors
- Other prominent vendors 

PART 13: Key vendor analysis
- ALLERGAN
- Anika Therapeutics
- Sanofi
- SEIKAGAKU
- Zimmer Biomet

……..CONTINUED